Clinical Trials in Chicago

Showing 61-80 of 17,609 trials

Nomad P-KAFO Study

NCT05644522

The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: * Wear a sensor that records everyday activities and mobility. * Perform measures of mobility and different activities of participation using their own brace. * Perform measures of mobility and different activities of participation using the Nomad powered KAFO

Cerebrovascular AccidentPost-polio SyndromeSpinal Cord Injuries+3 more

Shirley Ryan AbilityLab36 participantsStarted Mar 2024

Chicago, Illinois, United States

Active Not RecruitingPhase 32.2 miles

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

NCT01946204

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.

Prostatic Neoplasms

Aragon Pharmaceuticals, Inc.1,207 participantsStarted Oct 2013

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +376 more locations

Nomad P-KAFO Study

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Find Trials by Condition in Chicago

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

HF Patients With LVADs Being Treated With SGLT2i

Cognitive-Sensorimotor Function in Long-COVID

Neuromodulation and Neurorehabilitation for mTBI

A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer